USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA.

• 1. ROSUVASTATIN(ZD－4522)在制备治疗杂合家族性高胆固醇血症的药物中的应用 [P] . 中国专利： CN1268339C . 2006.08.09
• 2. ROSUVASTATIN(ZD－4522)在治疗杂合家族性高胆固醇血症中的应用 [P] . 中国专利： CN1630520A . 2005-06-22
• 3. Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia. [P] . ZA200303636B . 2004-08-12

  机译： 罗苏伐他汀（ZD-4522）在治疗杂合性家族性高胆固醇血症中的用途。

• 4. Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia [P] . AU2002214165B9 . 2013-07-04

  机译： 罗苏伐他汀（ZD-4522）在杂合性家族性高胆固醇血症的治疗中的应用

• 5. Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia [P] . AU2002214165B9 . 2013-08-29

  机译： 罗苏伐他汀（ZD-4522）在杂合性家族性高胆固醇血症的治疗中的应用

• 1. Prevalence of Cardiovascular Risk Factors and Heterozygous Familial Hypercholesterolemia in Premature Atherosclerotic Patients Presenting with Acute Coronary Syndrome [J] . Ahmed Ashraf Reda, Mahmoud Ali Soliman, Ahmed Mokhtar Elkersh, 心血管病（英文） . 2021,第003期
• 2. "Heterozygous Treatment"Method to Improve the Biased Status of the Damp-Heat Constitution and Symptom Integral:Randomized Controlled Trial [J] . Xianbing Hou, Haizhang Wang, Yanzhen Huo, 医学科学进展杂志(英文) . 2018,第001期
• 3. Combined cell transplantation in familial hypercholesterolemia. Preliminary study. [C] . Maganto P, Escudero C, Santos M, European Society for Surgical Research . 2011
• 4. Physician and patient influences in statin treatment adherence and associated outcomes in V.A. patients with hypercholesterolemia. [D] . Campione, Joanne Rita. 2005
• 5. LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late but not too late [O] . Agnieszka Mickiewicz, Marcin Fijałkowski, Andrzej Rynkiewicz, 2015
• 6. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label) [O] . Braamskamp, Marjet J. A. M., Langslet, Gisle, McCrindle, Brian W., 2017

• 1. Adult onset type 2 familial hemophagocytic lymphohistiocytosis with PRF1 c.65delC/c.163C>T compound heterozygous mutations: A case report [J] . Xin-Yi Liu ,Yan-Bo Nie ,Xue-Jing Chen . 世界临床病例杂志 . 2021,第010期
• 2. Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia [J] . Raul D Santos . 四川生理科学杂志 . 2021,第1期
• 3. Effect of LDL-apheresis on plasma lipids, chitotriosidase and anti-oxLDL antibodies in heterozygous familial hypercholes-terolemia [J] . Maria Musumeci ,Francesco Pappalardo ,GianCarlo Tonolo . 生物医学工程（英文） . 2009,第7期
• 4. 对比分析瑞舒伐他汀与阿托伐他汀在急性冠脉综合征治疗中的应用效果 [C] . 郑贯中 ,于永志 . 2015临床急症经验交流高峰论坛 . 2015
• 5. 膝关节置换术后应用低分子肝素钙、利伐沙班和阿司匹林在抗凝治疗中对于静脉血栓预防效果的对比 [A] . 陈治学 . 2019